SprintRay Expands 3D Dental Printing with EnvisionTEC Acquisition

In a significant move for the dental technology sector, SprintRay, a leading player in dental 3D printing, has officially acquired the dental product portfolio of EnvisionTEC/ETEC, which was previously part of Desktop Health. This strategic acquisition, announced on September 3, 2025, encompasses a wide range of assets, including patents, trademarks, inventory, and other intellectual property related to dental materials and 3D printing technologies.

This acquisition solidifies SprintRay's continuous dedication to advancing the field of dentistry, ensuring that dental professionals have access to advanced, reliable hardware and compliant resins. By bringing EnvisionTEC's extensive expertise and established product lines into its fold, SprintRay is poised to enhance its offerings and support for dental practitioners and laboratories worldwide.

The EnvisionTEC Legacy

EnvisionTEC has a storied history as one of the pioneers of 3D printing in dentistry. Over the past two decades, the company has secured over 200 patents focused on innovative 3D printing hardware and materials. It has also built a robust client base that includes dental labs and clinics around the globe. The acquisition integrates a significant amount of intellectual property and proven technologies into SprintRay, reinforcing its position as a key player in dental 3D printing.

Among the prominent technologies included in the deal is EnvisionTEC's patented Continuous Digital Light Manufacturing (cDLM) technology, known for its efficiency in the production of dental prosthetics. This technology, combined with the existing offerings under Desktop Health, including the Einstein-DLP printer series and the Flexcera materials, will enhance SprintRay's capabilities in delivering cutting-edge solutions to its customers. Flexcera, a hybrid nanoceramic resin, holds FDA 510(k) Class II and CE markings as well as MDR Class I certification, further underlining its regulatory compliance and clinical efficacy.

Commitment to Customers

SprintRay's leadership has emphasized the importance of maintaining high standards for customer support following this acquisition. Amir Mansouri, PhD, co-founder and CEO of SprintRay, noted, "The acquisition assures existing customers will continue to receive the tools and support they rely on, while simultaneously enhancing our offerings in dental labs." This commitment includes ongoing technical support for EnvisionTEC's customers, ensuring their practice operations run smoothly without interruption.

Furthermore, SprintRay plans to maintain the reliable supply of materials from EnvisionTEC, including the continued production of Flexcera resins, to ensure workflow continuity for dental professionals. The company is also exploring platform-wide validation of select EnvisionTEC materials on its systems, as well as evaluating the compatibility of its own resins with EnvisionTEC printers.

A New Era of Innovation

The expanded portfolio not only allows SprintRay to provide a more robust selection of technologies and materials tailored for dental laboratories but also establishes the company as a leader in setting new standards in the dental 3D printing industry. With this strategic acquisition, SprintRay is well-positioned to drive innovation in dental technology and to offer enhanced capabilities to its clients.

In addition to traditional 3D printing solutions, SprintRay is dedicated to advancing user-friendly innovations in dentistry, including AI-driven design software and efficient post-processing systems. These developments are designed to optimize practice efficiencies, expand lab capacities, and enable personalized patient care at scale.

With this acquisition, SprintRay is not just enhancing its product line but is also reaffirming its mission to revolutionize dentistry through accessible, reliable 3D printing technology.

For more information, visit SprintRay's website. Customers of EnvisionTEC/Desktop Health with inquiries or support needs can contact them directly at [email protected]. Please allow 5 to 7 business days for processing. Media inquiries can be directed to [email protected].